Jupiter Neurosciences Commences ~$2M Offering Of 307,692 Common Shares
Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous system disorders and neuroinflammation, today announced it
Jupiter Neurosciences is selling new shares of the company to raise about $2 million for its work on brain medicines. When a company sells new shares, it means there will be more shares out there, which can be important to watch when you're thinking about what each share might be worth.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.